24 In our patient cohort, patients on MMF had lower median antibody levels compared with patients without MMF, but the difference did not reach statistical significance ( Supplementary Figure 4 , C ).
← all excerpts
Humoral and Cellular Immune Response After Third and Fourth SARS-CoV-2 mRNA Vaccination in Liver Transplant Recipients.
2
—
—
The sentences
Other factors that showed a trend to be associated with lower antibody titers but did not reach significance were diabetes mellitus, first vaccination within the first year after LT, immunosuppressive therapy including mycophenolate mofetil (MMF), or combination therapy including calcineurin inhibitors (CNIs) compared with CNI monotherapy ( Supplementary Figure 4 ).